Global Fludeoxyglucose F 18 Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fludeoxyglucose F 18 Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fludeoxyglucose F 18 Injection is used for positron emission tomography (PET), and uses the characteristics of abnormal glucose metabolism of lesions for localization diagnosis and evaluation. 1. Used for tumor PET imaging to evaluate the malignancy of suspected or confirmed cases. 2. Used for PET imaging of coronary artery disease and left ventricular dysfunction. Combined with other myocardial perfusion imaging, it is used to evaluate the myocardial activity of the left ventricle and the recoverability of myocardial systolic function in cases of left ventricular dysfunction. 3. It is used to determine the epilepsy focus in epilepsy patients related to abnormal glucose metabolism.
Fludeoxyglucose F 18 Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fludeoxyglucose F 18 Injection market is projected to reach US$ 177.6 million in 2029, increasing from US$ 109 million in 2022, with the CAGR of 7.2% during the period of 2024 to 2029. Demand from Cancer and Heart Disease are the major drivers for the industry.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
＜200 mCi/1mL
200-300 mCi/1mL
＞300 mCi/1mL
Cancer
Heart Disease
Epilepsy
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fludeoxyglucose F 18 Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fludeoxyglucose F 18 Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fludeoxyglucose F 18 Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fludeoxyglucose F 18 Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fludeoxyglucose F 18 Injection introduction, etc. Fludeoxyglucose F 18 Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Fludeoxyglucose F 18 Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Fludeoxyglucose F 18 Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fludeoxyglucose F 18 Injection market is projected to reach US$ 177.6 million in 2029, increasing from US$ 109 million in 2022, with the CAGR of 7.2% during the period of 2024 to 2029. Demand from Cancer and Heart Disease are the major drivers for the industry.
Fludeoxyglucose F 18 Injection is currently the most widely used positron radioactive drug in clinical practice.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fludeoxyglucose F 18 Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.,Ltd.
Hta Co., Ltd
Guangdong Cyclotron Medical Science Co., Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
China Isotope & Radiation Corporation
Segment by Type
＜200 mCi/1mL
200-300 mCi/1mL
＞300 mCi/1mL
Segment by Application
Cancer
Heart Disease
Epilepsy
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fludeoxyglucose F 18 Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fludeoxyglucose F 18 Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fludeoxyglucose F 18 Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fludeoxyglucose F 18 Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fludeoxyglucose F 18 Injection introduction, etc. Fludeoxyglucose F 18 Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Fludeoxyglucose F 18 Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices